buserelin has been researched along with Peritoneal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furui, T; Imai, A; Sugiyama, M; Takahashi, S; Tamaya, T | 1 |
| Aoki, R; Banno, K; Iwata, T; Kubushiro, K; Nozawa, S; Tsukazaki, K; Yamashita, H | 1 |
1 trial(s) available for buserelin and Peritoneal Diseases
| Article | Year |
|---|---|
Gonadotrophin-releasing hormones agonist therapy increases peritoneal fibrinolytic activity and prevents adhesion formation after myomectomy.
Topics: Adult; Buserelin; Female; Humans; Infertility, Female; Peritoneal Diseases; Plasminogen Activator Inhibitor 1; Plasminogen Activators; Postoperative Complications; Premedication; Prospective Studies; Second-Look Surgery; Severity of Illness Index; Tissue Adhesions; Treatment Outcome | 2003 |
1 other study(ies) available for buserelin and Peritoneal Diseases
| Article | Year |
|---|---|
Gonadotropin-releasing hormone analogue therapy for peritoneal inclusion cysts after gynecological surgery.
Topics: Adult; Buserelin; Cysts; Female; Genitalia, Female; Humans; Hysterectomy; Leiomyoma; Leuprolide; Magnetic Resonance Imaging; Middle Aged; Ovariectomy; Peritoneal Diseases; Postoperative Complications; Recurrence; Treatment Outcome; Ultrasonography; Uterine Neoplasms | 2000 |